InvestorsHub Logo
Followers 38
Posts 1440
Boards Moderated 0
Alias Born 03/07/2004

Re: jbainseky post# 176051

Sunday, 05/11/2014 7:43:48 PM

Sunday, May 11, 2014 7:43:48 PM

Post# of 346155
jbain. what's your timetable for approval? The first PIII "look=in" for PPHM's Bavituximab is when? Looks like we might be licensing for various different disease indications.
The factoid to keep in mind is that the pharmokinetics indicate Bavi will be orders of magnitude more effective for early disease states (e.g. chronic inflammatory states) than for incurable, end-stage cancer. Looks to me like safety AND efficacy for naked Bavi. Imagine Bavi with a payload for, say, rheumatoid arthritis, or myocarditis, or, or....?Alzheimers?.....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News